Clinical trial data referenced in this article reflects outcomes from large clinical trials of FDA-approved branded medications and does not represent BreezeMeds-specific outcomes or guaranteed results for compounded formulations
Figure 1: Reimbursement of Wegovy in commercial plans, February 2024 Source: Clarivate Fingertip Analytics, accessed February 2024 Likely impact of rebating The current highly favorable reimbursement environment for Wegovy is likely tied to extensive rebates offered by Novo Nordisk to payers
Specifically designed to complement GLP-1 medications, this powerful formula supports digestion, regularity, energy levels, and healthy weight loss
Most of the public is unaware of the Trump administrations recent prescription drug announcements, with less than a third saying theyve read or heard a lot or some about President Trumps deals to lower the cost of certain drugs for state Medicaid programs (30%), efforts to reduce the cost of some IVF drugs (24%), or the planned TrumpRx website (20%)